As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

As of last year, RSV vaccination with Abrysvo has been recommended for pregnant women in the United States from 32 to 36 ...

These miniature immune system models — known as human immune organoids — mimic the real-life environment where immune cells ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The study presents two cases of TTP occurring after the administration of the vaccine, highlighting the potential association ... with a gradual return to normal values for ADAMTS13 antigen and ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

Our synthetic hydrogels create a breakthrough environment for human immune organoids, allowing us to model antibody production from scratch ... especially in the context of immunity, infection, and ...